关注
Neal Lindeman
Neal Lindeman
Professor of Pathology and Laboratory Medicine, Weill Cornell Medicine
在 med.cornell.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
JG Paez, PA Janne, JC Lee, S Tracy, H Greulich, S Gabriel, P Herman, ...
Science 304 (5676), 1497-1500, 2004
120152004
MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
JA Engelman, K Zejnullahu, T Mitsudomi, Y Song, C Hyland, JO Park, ...
science 316 (5827), 1039-1043, 2007
54602007
Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists …
NI Lindeman, PT Cagle, MB Beasley, DA Chitale, S Dacic, G Giaccone, ...
Journal of Thoracic Oncology 8 (7), 823-859, 2013
19462013
Standards and guidelines for the interpretation and reporting of sequence variants in cancer: a joint consensus recommendation of the Association for Molecular Pathology …
MM Li, M Datto, EJ Duncavage, S Kulkarni, NI Lindeman, S Roy, ...
The Journal of molecular diagnostics 19 (1), 4-23, 2017
16132017
Updated molecular testing guideline for the selection of lung cancer patients for treatment with targeted tyrosine kinase inhibitors: guideline from the College of American …
NI Lindeman, PT Cagle, DL Aisner, ME Arcila, MB Beasley, EH Bernicker, ...
Archives of pathology & laboratory medicine 142 (3), 321-346, 2018
15182018
AACR Project GENIE: powering precision medicine through an international consortium
AACR Project Genie Consortium, AACR Project GENIE Consortium, ...
Cancer discovery 7 (8), 818-831, 2017
13192017
Characterizing the cancer genome in lung adenocarcinoma
BA Weir, MS Woo, G Getz, S Perner, L Ding, R Beroukhim, WM Lin, ...
Nature 450 (7171), 893-898, 2007
12802007
Preexistence and clonal selection of MET amplification in EGFR mutant NSCLC
AB Turke, K Zejnullahu, YL Wu, Y Song, D Dias-Santagata, E Lifshits, ...
Cancer cell 17 (1), 77-88, 2010
12372010
EML4-ALK Fusion Gene and Efficacy of an ALK Kinase Inhibitor in Lung Cancer
JP Koivunen, C Mermel, K Zejnullahu, C Murphy, E Lifshits, AJ Holmes, ...
Clinical cancer research 14 (13), 4275-4283, 2008
12362008
LKB1 modulates lung cancer differentiation and metastasis
H Ji, MR Ramsey, DN Hayes, C Fan, K McNamara, P Kozlowski, C Torrice, ...
Nature 448 (7155), 807-810, 2007
11762007
Acute myeloid leukemia ontogeny is defined by distinct somatic mutations
RC Lindsley, BG Mar, E Mazzola, PV Grauman, S Shareef, SL Allen, ...
Blood, The Journal of the American Society of Hematology 125 (9), 1367-1376, 2015
9982015
Circulating tumor DNA analysis in patients with cancer: American Society of Clinical Oncology and College of American Pathologists joint review
JD Merker, GR Oxnard, C Compton, M Diehn, P Hurley, AJ Lazar, ...
Archives of pathology & laboratory medicine 142 (10), 1242-1253, 2018
9702018
Unique Clinicopathologic Features Characterize ALK-Rearranged Lung Adenocarcinoma in the Western Population
SJ Rodig, M Mino-Kenudson, S Dacic, BY Yeap, A Shaw, JA Barletta, ...
Clinical cancer research 15 (16), 5216-5223, 2009
8512009
A novel ALK secondary mutation and EGFR signaling cause resistance to ALK kinase inhibitors
T Sasaki, J Koivunen, A Ogino, M Yanagita, S Nikiforow, W Zheng, ...
Cancer research 71 (18), 6051-6060, 2011
7102011
Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non–small cell lung cancer patients treated with gefitinib or erlotinib
DM Jackman, BY Yeap, LV Sequist, N Lindeman, AJ Holmes, VA Joshi, ...
Clinical Cancer Research 12 (13), 3908-3914, 2006
7012006
Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine
EM Van Allen, N Wagle, P Stojanov, DL Perrin, K Cibulskis, S Marlow, ...
Nature medicine 20 (6), 682-688, 2014
5662014
A Novel, Highly Sensitive Antibody Allows for the Routine Detection of ALK-Rearranged Lung Adenocarcinomas by Standard Immunohistochemistry
M Mino-Kenudson, LR Chirieac, K Law, JL Hornick, N Lindeman, EJ Mark, ...
Clinical Cancer Research 16 (5), 1561-1571, 2010
5472010
MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele …
L Xu, ZR Hunter, G Yang, Y Zhou, Y Cao, X Liu, E Morra, A Trojani, ...
Blood, The Journal of the American Society of Hematology 121 (11), 2051-2058, 2013
4492013
Phase II clinical trial of chemotherapy-naive patients≥ 70 years of age treated with erlotinib for advanced non–small-cell lung cancer
DM Jackman, BY Yeap, NI Lindeman, P Fidias, MS Rabin, J Temel, ...
Journal of Clinical Oncology 25 (7), 760-766, 2007
4292007
Sensitive mutation detection in heterogeneous cancer specimens by massively parallel picoliter reactor sequencing
RK Thomas, E Nickerson, JF Simons, PA Jänne, T Tengs, Y Yuza, ...
Nature medicine 12 (7), 852-855, 2006
4282006
系统目前无法执行此操作,请稍后再试。
文章 1–20